美护行业：把握向上势能，关注新品催化－美护25年中报综述

医药行业：港股创新药进入盈利期－港股医药行业2025年半年报总结

医药行业：千店千面，开启差异化发展路线－药店行业新业态系列

医药行业：产业复苏，配置拐点－CXO 2025H1业绩综述

医药生物行业：轻舟已过万重山，再举云帆万里程，积极把握新一轮产业周期－2025中报分析之CRO、CD

医药生物行业：底部夯实，寻求“拐点、成长_共振

医药生物行业：创新药授权出海后，下一步剧本是什么？－叙事经济学视角的创新药择时策略

Genomic data analysis and interpretation involve the process of analyzing the vast amount of information contained in an organism's deoxyribonucleic acid (DNA) to understand its structure, function and variations. This field uses computational tools, bioinformatics and statistical methods to process raw genomic data, such as sequences of nucleotides and interpret their biological significance.

Generic pharmaceuticals are copies of known brand-name drugs that have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety and strength as the original drug. Their pharmacological effects are exactly the same as those of their brand-name counterparts. An example of a generic drug used for diabetes, is Metformin. The brand name for Metformin is Glucophage. A generic drug used for Hypertension, is Metoprolol, whereas the brand name for the same drug is Lopressor.

The global population health management market was sized near USD 79.33 billion in 2023 in terms of value. The global population health management market is witnessing dynamic growth, largely driven by the increasing shift toward value-based care and the integration of digital health technologies. Key market trends include the widespread adoption of data analytics and artificial intelligence tools, enabling healthcare providers to more effectively manage patient populations, predict health risks, and improve outcomes. This is coupled with a growing emphasis on preventive care and chronic disease management, as healthcare systems worldwide aim to reduce costs while enhancing quality of care. Moreover, the increasing focus on patient-centred care, where individuals are empowered to engage in their health management through digital platforms and wearable devices, is contributing to market expansion. The market is also benefiting from government initiatives promoting the use of health data for better resource allocation and improved care coordination.